Curaleaf (CURLF) Stock Price, News & Analysis

Company Overview

Curaleaf Holdings, Inc. is a cannabis company that cultivates, processes and sells cannabis products for medical and adult-use markets. Its products include cannabis flower, pre-rolls, concentrates, vapes, edibles, tinctures and topical products, sold under brands including Curaleaf, Select and Grassroots.

The company operates across multiple U.S. markets through cultivation and processing facilities, wholesale operations and retail dispensaries. Through Curaleaf International, it also serves medical cannabis markets in Europe and other international markets.

Curaleaf traces its origins to 2010 and adopted the Curaleaf name in 2018. Boris Jordan is the company’s executive chairman, and Matt Darin serves as chief executive officer.

Key Stats

• Today's Range: $8.58 to $9.10
• 50-Day Range: $7.63 to $11.90
• 52-Week Range: $5.40 to $15.15
• Volume: 74,905 shs
• Average Volume: 280,206 shs
• Market Capitalization: $2.06 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Buy

Curaleaf Stock Analysis - MarketRank™

Curaleaf scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Curaleaf has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 2 buy ratings, 1 hold rating, and no sell ratings.

Downside Risk

Curaleaf has a consensus price target of $6.00, representing about 33.4% downside from its current price of $9.01.

Amount of Analyst Coverage

Curaleaf has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Curaleaf are expected to decrease in the coming year, from $0.05 to ($0.37) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Curaleaf is -225.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Curaleaf is -225.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Curaleaf has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.44% of the float of Curaleaf has been sold short.

Short Interest Ratio / Days to Cover

Curaleaf has a short interest ratio ("days to cover") of 4.56.

Change versus previous month

Short interest in Curaleaf has recently decreased by 5.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Curaleaf does not currently pay a dividend.

Dividend Growth

Curaleaf does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.33

News Sentiment

Curaleaf has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Curaleaf this week, compared to 3 articles on an average week.

Search Interest

Only 2 people have searched for CURLF on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

MarketBeat Follows

10 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Curaleaf insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.03% of the stock of Curaleaf is held by institutions.

Company Calendar

• Last Earnings: 11/03/2026
• Today: 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CURLF
• CIK: 1756770
• Web: www.curaleaf.com
• Phone: 781-451-0351
• Fax: N/A
• Employees: 5,554
• Year Founded: 2009

Price Target and Rating

• Average Price Target for Curaleaf: $6.00
• High Price Target: $6.00
• Low Price Target: $6.00
• Potential Upside/Downside: -31.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$231.07 million
• Net Margins: -0.76%
• Pretax Margin: -7.55%
• Return on Equity: 0.43%
• Return on Assets: 0.13%

Debt

• Debt-to-Equity Ratio: 1.09
• Current Ratio: 1.61
• Quick Ratio: 0.78

Sales & Book Value

• Annual Sales: $1.27 billion
• Price / Sales: 1.62
• Cash Flow: $0.16 per share
• Price / Cash Flow: 54.61
• Book Value: $3.63 per share
• Price / Book: 2.42

Miscellaneous

• Outstanding Shares: 233,650,000
• Free Float: N/A
• Market Cap: $2.05 billion
• Optionable: Not Optionable
• Beta: 1.62